Clinical Trial Update: 68 Ga-NODAGA-E[c(RGDγK)]2: Positron Emission Tomography Tracer for Imaging of Myocardial Angiogenesis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for a PET imaging tracer targeting myocardial angiogenesis in acute myocardial infarction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• 68 Ga-NODAGA-E[c(RGDγK)]2 (Ga-68 NODAGA-E[c(RGDγK)]2)

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Acute Myocardial Infarction | Phase 2 | Status: COMPLETED